Recent NBIX News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/15/2026 08:18:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2026 08:17:58 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2026 08:15:43 PM
- Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results • PR Newswire (US) • 04/14/2026 08:01:00 PM
- Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR • PR Newswire (US) • 04/14/2026 12:30:00 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 04/06/2026 09:08:18 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 04/06/2026 11:39:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 11:35:19 AM
- Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio • PR Newswire (US) • 04/06/2026 11:00:00 AM
- Neurocrine unveils first expert guidance for tardive dyskinesia care in long-term facilities • IH Market News • 03/26/2026 03:27:23 PM
- Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings • PR Newswire (US) • 03/26/2026 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:56:51 PM
- Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer • PR Newswire (US) • 03/17/2026 08:05:00 PM
- Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum • PR Newswire (US) • 03/10/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:18:36 PM
- Neurocrine Biosciences to Present at Upcoming Investor Conferences in March • PR Newswire (US) • 02/24/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 12:12:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:49:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:48:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:48:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:47:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:46:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:46:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:45:01 PM
